Pharmaceutical Industry Information Portal

HomeNews

News

EMA approves new site for manufacture of Moderna Covid-19 vaccine in France

The European Medicines Agency (EMA) announced on June 11, 2021 that its committee for human medicines (CHMP) has approved a new manufacturing site for the...

Bayer builds a new pharmaceutical facility in Finland

Bayer is building a new pharmaceutical facility in Turku and at the same time modernizing its existing production plant. The new production facility will...

Tatyana Golikova: Russia should minimize imports of medicines

Russia should minimize its dependence on imports of ready-made medicines and pharmaceutical substances, Russian Deputy Prime Minister Tatyana Golikova said on Thursday. /TASS/ "In 2020,...

Vaxzevria: EMA advises against use in people with history of capillary leak syndrome

EMA’s safety committee (PRAC) has concluded that people who have previously had capillary leak syndrome must not be vaccinated with Vaxzevria (formerly COVID-19 Vaccine...

Egyptian company SOLYPHAR will build a pharmaceutical company in Uzbekistan

It is envisaged to implement the project in three stages from 2021 to 2024, the amount of investment from the company "SOLYPHAR" will be more than 20 million US dollars, in accordance to the international GMP standards.

Sputnik V demonstrates 94.3% efficacy during the vaccination campaign in Bahrain

An efficacy study was conducted in Bahrain in accordance with WHO guidelines involving more than 5,000 subjects. Overall efficacy beyond 14 days after administering the second dose was estimated at 94.3%.
spot_img

Expert Articles

spot_img